{
 "generic_name": "Methotrexate Sodium Injection",
 "slug": "methotrexate-sodium-injection",
 "brand_names": [
  "Methotrexate"
 ],
 "fda_status": [
  "Current"
 ],
 "last_fda_update": "09/22/2026",
 "first_posted": "03/13/2023",
 "synced_at": "2026-10-01T04:04:04.751Z",
 "presentations": [
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0143-9830-01",
   "presentation": "Methotrexate, Preservative Free, Injection, 1 g (NDC 0143-9830-01)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Additional lots will be available in the September 2026 timeframe.  Product will be made available as it is released."
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-122-50",
   "presentation": "Methotrexate Preservative Free, Injection, 1 g (NDC 63323-122-50)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Check wholesaler for inventory"
  },
  {
   "company": "Accord Healthcare Inc.",
   "package_ndc": "16729-277-30",
   "presentation": "Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-30)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Estimated recovery: late September 2026; Short dated inventory with expiry of 09/30/27 available"
  },
  {
   "company": "Accord Healthcare Inc.",
   "package_ndc": "16729-277-35",
   "presentation": "Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-35)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Short dated inventory with expiry of 8/31/2027 available; Estimated recovery: TBD"
  },
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0143-9519-10",
   "presentation": "Methotrexate, Preservative Free, Injection, 25 mg/1 mL (NDC 0143-9519-10)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Additional lots will be available in the October 2026 timeframe.  Product will be made available as it is released."
  },
  {
   "company": "Teva Pharmaceuticals USA, Inc.",
   "package_ndc": "0703-3671-01",
   "presentation": "Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3671-01)",
   "availability": "Limited",
   "availability_raw": "Limited Availability",
   "fda_note": "Estimated recovery: October 2026"
  },
  {
   "company": "Teva Pharmaceuticals USA, Inc.",
   "package_ndc": "0703-3678-01",
   "presentation": "Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01)",
   "availability": "Limited",
   "availability_raw": "Limited Availability",
   "fda_note": "Estimated recovery: October 2026"
  },
  {
   "company": "Teva Pharmaceuticals USA, Inc.",
   "package_ndc": "0703-3675-01",
   "presentation": "Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3675-01)",
   "availability": "Limited",
   "availability_raw": "Limited Availability",
   "fda_note": "Estimated recovery: December 2026"
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-123-10",
   "presentation": "Methotrexate Sodium, Injection, 25 mg/1 mL (NDC 63323-123-10)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Check wholesaler for inventory"
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "61703-124-40",
   "presentation": "Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-124-40)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "61703-408-25",
   "presentation": "Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-25)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "61703-408-41",
   "presentation": "Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-41)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "61703-350-10",
   "presentation": "Methotrexate Sodium, Injection, 50 mg/2 mL  (25 mg/mL) (NDC 61703-350-10)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "61703-350-38",
   "presentation": "Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-38)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  }
 ],
 "changes": []
}